1

Slowing down skin cancer

Experimental drug shrinks tumours, extends lifespan


 

An experimental drug can shrink skin cancer tumours, according to early stage trials of the new treatment. U.S. researchers call this “unprecedented.” Within two weeks of receiving the drug, 31 patients whose skin cancer had travelled throughout their body, saw their tumours shrink. The drug is called PLX4032, and it acts by blocking the gene BRAF that causes skin cancer to spread. This follows a recent trend in cancer research, where blocking gene activity via medication has been helpful in treating myloid leukaemia and gastric cancer. Not only is the speedy shrinkage exciting, but so is the fact that 70 per cent of patients who have been given the drug have responded well. Other cancer treatments, including chemotherapy, do not always work. The research is being presented at cancer conference in Berlin. The researchers stress that while this is not a cure, it should improve the quality of life of skin cancer patients and slow their deterioration.

BBC News


 
Filed under:

Slowing down skin cancer

  1. Progress such as this is showing that we are getting closer to eradicating cancer.

    My name is Emily Ward and I work with the Canadian Cancer Society on a new campaign called "Join the Fight!"

    Donations raised from this campaign will go towards funding cancer research and support groups.

    We are looking for people who have been affected by cancer to share their stories on our Facebook page. If you are interested, please visit http://www.facebook.com/event.php?eid=13452696344

    Thank you,

    Emily

Sign in to comment.